AR-R15896AR reduces cerebral infarction volumes after focal ischemia in cats

Neurosurgery

Volumn 46, Issue 3, 2000, Pages 710-720

  Sutherland, Garnette R ^a   Perron, Justin T ^a   Kozlowski, Piotr ^b   McCarthy, Dennis J ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c ASTRAZENECA   (United Kingdom)

Author keywords

AR R15896AR; Focal cerebral ischemia; Magnetic resonance imaging; N methyl D aspartate antagonists; Neuroprotection

Indexed keywords

CALCIUM; LANICEMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CALCIUM BLOOD LEVEL; CAT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG TISSUE LEVEL; FEMALE; HISTOPATHOLOGY; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL;

EID: 0034061546     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200003000-00035     Document Type: Article

References (61)

1. Barzo P, Marmarou A, Fatouros P, Ito J, Corwin F: MRI diffusion-weighted spectroscopy of reversible and irreversible ischemic injury following closed head injury. Acta Neurochir Suppl (Wien) 70:115-118, 1997.
2. Bederson JB, Bartkowski HM, Moon K, Halks-Miller M, Nishimura MC, Brant-Zawadski M, Pitts LH: Nuclear magnetic imaging and spectroscopy in experimental brain edema in a rat model. J Neurosurg 64:795-802, 1986.
3. Belayev L, Busto R, Zhao W, Ginsberg MD: HU-211, a novel non-competitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal ischemia in the rat. Stroke 26:2313-2320, 1995.
4. Benveniste H, Drejer J, Schousboe A, Diemer NH: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369-1374, 1984.
5. Black MA, Tremblay R, Mealing G, Ray R, Durkin JP, Whitfield JF, Blosser J, Morley P: N-Methyl-D-aspartate or glutamate-mediated toxicity in cultured rat cortical neurons is antagonized by FPL 15896AR. J Neurochem 65:2170-2177, 1995.
6. Bubser M, Keseberg U, Notz PK, Schmidt WJ: Differential behavioural and neurochemical effects of competitive and noncompetitive NMDA receptor antagonists in rats. Eur J Pharmacol 229:75-82, 1992.
7. Buchan A, Pulsinelli WA: Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci 10:311-316, 1990.
8. Bullock R, Graham DI, Chen MH, Low D, McCulloch J: Focal ischemia in the cat: Pre-treatment with a competitive NMDA receptor antagonist, D-CPP-ene. J Cereb Blood Flow Metab 10: 668-674, 1990.
9. Chen HSV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA: Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated toxicity. J Neurosci 12:4427-4435, 1992.
10. Choi DW: Ionic dependence of glutamate neurotoxicity. J Neurosci 7:369-379, 1987.
11. Choi DW: Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci 11:463-469, 1988.
12. Corbett D, Evans S, Thomas C, Wang D, Jonas RA: MK-801 reduces cerebral ischemic injury by inducing hypothermia. Brain Res 514:300-304, 1990.
13. Cox JA, Lysko PG, Henneberry RC: Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: Role of the voltage-dependent magnesium block. Brain Res 499:267-272, 1989.
14. Cregan EF, Peeling J, Corbett D, Buchan AM, Saunders J, Auer RN, Gao M, McCarthy DJ, Eisman MS, Campbell TM, Murray RJ, Stagnitto ML, Palmer GC: [(S)-α-Phenyl-2-pyridine-ethanamine dihydrochloride], a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia. J Pharmacol Exp Ther 283:1412-1424, 1997.
15. Dingledine R, Boland RM, Chamberlin NL, Kawasaki K, Kleckner NW, Traynelis SF, Verdoon TA: Amino acid receptors and uptake systems in the mammalian central nervous system. Crit Rev Neurobiol 4:1-96, 1988.
16. Dubinsky JM: Examination of the role of calcium in neuronal death. Ann N Y Acad Sci 697:34-42, 1993.
17. Foster AC, Fagg GE: Taking apart NMDA receptors. Nature 329:395-396, 1987.
18. Gibbons SJ, Brorson JR, Bleakman D, Chard PS, Miller RJ: Calcium influx and neurodegradation. Ann N Y Acad Sci 697:22-33, 1993.
19. Greenberg JH, Uematsu D, Araki N, Reivich M: Intracellular calcium and the pathophysiological changes in cerebral ischemia. Arzneimittelforschung 41:324-332, 1991.
20. Greene JG, Porter RHP, Greenamyre JT: ARL 15896AR, a novel N-methyl-D-aspartate receptor ion channel antagonist: Neuroprotection against mitochondrial metabolic toxicity and regional pharmacology. Exp Neurol 137:66-72, 1996.
21. Hartley DM, Choi DW: Delayed rescue of N-methyl-D-aspartate receptor mediated neuronal injury in cortical culture. J Pharmacol Exp Ther 250:752-758, 1989.
22. Hasegawa Y, Fisher M, Baron BM, Metcalf G: The competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke. Stroke 25:1241-1246, 1994.
23. Helfaer MA, Ichord RN, Martin LJ, Hum PD, Castro A, Traystman RJ: Treatment with the competitive NMDA antagonist GPI 3000 does not improve outcome after cardiac arrest in dogs. Stroke 29:824-829, 1998.
24. Hoffman WE, Charbel FT, Edelman G, Ausman JI: Thiopental and desflurane treatment for brain protection. Neurosurgery 43:1050-1053, 1998.
25. Hudzik TJ, Palmer GC: Effects of anticonvulsants in a novel operant learning paradigm in rats: Comparison of remacemide hydrochloride and FPL 15896AR to other anticonvulsant agents. Epilepsy Res 21:183-193, 1995.
26. Hudzik JT, Freedman L, Palmer GC: Remacemide hydrochloride and ARL 15896AR lack abuse potential: Additional differences from other uncompetitive NMDA antagonists. Epilepsia 37:544-550, 1996.
27. Jiang N, Chopp M, Stein D, Feit H: Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 735:101-107, 1996.
28. Kimura R, Shiino A, Matsuda M, Handa J, Morikawa S, Inubushi T: Acute focal cerebral ischemia in rats studied by diffusion weighted magnetic resonance imaging: An experimental study. Surg Neurol 46:67-74, 1996.
29. Kirsch JR, Traystman RJ, Hurn PD: Anesthetics and cerebroprotection: Experimental aspects. Int Anesthesiol Clin 34:73-93, 1996.
30. Knight RA, Dereski MO, Helpern JA, Ordidge RJ, Chopp M: Magnetic resonance imaging assessment of evolving focal cerebral ischemia: Comparison with histopathology in rats. Stroke 25:1252-1262, 1994.
31. Koek W, Colpaert FC: Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: Relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 252:349-357, 1989.
32. Korf JH, Klein C, Venema K, Postema F: Increases in striatal and hippocampal impedance and extracellular levels of amino acids bv cardiac arrest in freely moving rats. J Neurochem 50:1087-1096, 1990.
33. Lanier WL, Perkins WJ, Karlsson BR, Milde JH, Scheithauer BW, Shearman GT, Michenfelder JD: The effects of dizocilpine maleate (MK-801), an antagonist of the N-methyl-D-aspartate receptor, on neurologic recovery and histopathology following complete cerebral ischemia in primates. J Cereb Blood How Metab 10:252-261, 1990.
34. Lysko PG, Cox JA, Vigano MA, Henneberry RC: Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: Pharmacological characterization. Brain Res 499: 258-266, 1989.
35. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ, Barker JL: NMDA receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 321:519-522, 1986.
36. Matsumoto M, Zornow MH, Scheller MS, Strnat MA: AMPA and NMDA receptor antagonists do not increase hippocampal glutamate concentrations during transient global ischemia. Anesthesiology 77:764-771, 1992.
37. Mayer ML, Westbrook GL: The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 28:197-276, 1987.
38. Deleted in proof.
39. Mealing GAR, Lanthorn TH, Murray CL, Small DL, Morley P: Differences in degree of trapping of low affinity uncompetitive N-methyl-D-aspartic acid receptor antagonists with similar kinetics of block. J Pharmacol Exp Ther 288:204-210, 1999.
40. Mealing GAR, Lanthorn TH, Small DL, Black MA, Laferriere NB, Morley P: Antagonism of N-methyl-D-aspartate-evoked currents in rat cortical cultures by ARL15896AR. J Pharmacol Exp Ther 281:376-383, 1997.
41. Michaels RL, Rothman SM: Glutamate neurotoxicity in vitro: Antagonist pharmacology and intracellular calcium concentrations. J Neurosci 10:283-292, 1990.
42. 2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med 18:39-50, 1991.
43. Mori E, Tabuchi M, Yoshida T, Yamadori A: Intracarotid urokinase with thromboembolism occlusion of the middle cerebral artery. Stroke 19:802-812, 1988.
44. Deleted in proof.
45. O'Brien MD, Waltz AG: Intracranial pressure gradients caused by experimental cerebral ischemia and edema. Stroke 4:694-698, 1973.
46. Deleted in proof.
47. Palmer GC, Cregan EF, Borrelli AR, Harris EW, Stagnitto ML, Colombo P, Kaiser FC, Murray RJ, Griffith RC, Strand JC: Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia. J Pharmacol Exp Ther 274:991-1000, 1995.
48. Palmer GC, Murray RJ, Cramer CL, Stagnitto ML, Knowles MK, Freedman LR, Eisman MS, Mahmood N, Balestra M, Borrelli AR, Hudzik TJ, McCarthy DJ: [S]-AR-R15896AR: A novel anticonvulsant - Acute safety, pharmacokinetics, and pharmacodynamic properties. J Pharmacol Exp Ther 288:121-132, 1999.
49. Sauer D, Allegrini PR, Cosenti A, Pataki A, Amacker H, Fagg GE: Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: An in vivo magnetic resonance imaging study. J Cereb Blood Flow Metab 13:595-602, 1993.
50. Shuaib A, Ijaz S, Mazagri R, Senthilsevlvan A: CGS-19755 is neuroprotective during repetitive ischemia: This effect is significantly enhanced when combined with hypothermia. Neuroscience 56:915-920, 1993.
51. Simon RP, Swan JH, Griffiths T, Meldrum BS: Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226:850-852, 1984.
52. Stevens FC: On to molecular mechanisms. Nature 358:18-19, 1992.
53. Todd MM, Drummond JC: A comparison of the cerebrovascular and metabolic effects of halothane and isoflurane in the cat. Anesthesiology 60:276-282, 1984.
54. 2-weighted increases in magnetic resonance images of immature brain during hypoxia-ischemia: Transient reversal posthypoxia. Exp Neurol 150:321-328, 1998.
55. Deleted in proof.
56. Wang Q, Santizo R, Baughman VL, Pelligrino DA: Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 30:630-637, 1999.
57. Warner DS, Zhou J, Ramani R, Todd MM: Reversible focal ischemia in the rat: Effects of halothane, isoflurane, and methohexital anesthesia. J Cereb Blood Flow Metab 11:794-802, 1991.
58. Watkins JC, Evans RH: Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 21:165-204, 1981.
59. Watkins JC, Olverman HJ: Agonists and antagonists for excitatory amino acid receptors. Trends Neurosci 10:265-272, 1987.
60. Zhu CZ, Auer RN: Graded hypotension and MCA occlusion duration: Effect in transient focal ischemia. J Cereb Blood Flow Metab 15:980-988, 1995.
61. Zivin J, Fisher M, DeGirolami U, Hemenway CC, Stashak JA: Tissue plasminogen activator reduces neurologic damage after cerebral embolism. Science 230:1289-1292, 1985.